Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial

  • PDF / 1,071,374 Bytes
  • 8 Pages / 595.276 x 790.866 pts Page_size
  • 78 Downloads / 181 Views

DOWNLOAD

REPORT


ORIGINAL ARTICLE

Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial Su Youn Nam1   · Sang Won Lee1 · Seong Woo Jeon1 · Yong Hwan Kwon1 · Hyun Seok Lee1 Received: 31 August 2019 / Accepted: 9 January 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020

Abstract Background  Helicobacter pylori infection and hyperplastic polyp are known to have strong connections, but there are not enough randomized controlled trial data. Aims  To evaluate the effect of H. pylori eradication on gastric hyperplastic polyp. Method  This is an open-labeled, single-center, randomized controlled trial. Patients with hyperplastic polyp and current infection of H. pylori were randomly assigned to eradication or non-eradication groups. All participants underwent followup endoscopy to investigate the regression of gastric polyps. Gastric polyp regression was defined as the disappearance of polyps or a reduction of more than 50% in size. Results  Thirty-two patients were randomized to eradication (n = 17) and non-eradication groups (n = 15). Final included patients were 14 in eradication group and 13 in non-eradication group. All patients showed polyp regression in eradication group, whereas no regression was observed in non-eradication group (P